The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: inhibition of dendritic cell functions via Toll like receptor 9 signaling
Open accessAbstract
Hydroxychloroquine (HCQ) is one of the most commonly prescribed immune-suppressants in treating rheumatoid arthritis (RA). Our previous research showed that HCQ suppressed RA development by inhibiting T follicular helper (Tfh) cells directly. Dendritic cells (DCs) serve as the link between innate and acquired immunity. Whether HCQ suppressed Tfh cell through DCs was not clear. In current study, we found that HCQ efficiently inhibited CD86, chemokine (C-X-C motif) receptor 4 (CXCR4) expression and interferon-α (IFN-α) secretion of healthy donor derived purified DCs stimulated by RA patient serum. To mimic RA, collagen-induced arthritis (CIA) mouse model was used and treated with HCQ daily for fifty-four days prior to sacrifice. We found HCQ inhibited DC maturation and migration to lymph nodes (LNs), manifested as down-regulated expression of CD40, CD80, CD86, MHCII (I-Aq) on LN DCs. In addition, HCQ reduced the level of chemokine receptor 7 (CCR7) and L-selectin on peripheral blood DCs and diminished percentage of LN DCs. Of note, HCQ only inhibited CpG ODN 1826-induced IL-12 secretion by bone marrow DCs (BMDCs) stimulated by various toll like receptor (TLR) agonists. Mechanistically, HCQ down-regulated the expression of TLR9 not only in healthy donor PBMC-derived DCs stimulated by RA patient serum, but also in LN DCs of CIA mice and CpG-activated BMDCs. Furthermore, arthritis scores in TLR9−/− mice were much lower than that in wild type mice with impaired maturity and migration capability of DCs. Collectively, activation of DCs contributes to the pathogenesis of RA and HCQ shows protective effects on RA by inhibition of DC activation via blocking TLR9.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hydroxychloroquine has been purported to interact with and antagonise the key intracellular nucleic acid sensors TLR9 and cGAS, which likely contribute to its clinical efficacy in rheumatoid arthritis and systemic lupus erythematosus.
“Hydroxychloroquine has been purported to interact with and antagonise the key intracellular nucleic acid sensors, TLR9 and cGAS, which likely contribute to its clinical efficacy in rheumatoid arthritis and systemic lupus erythematous (Han et al., 2020).”
From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as Han et al., 2020
The Discussion supports hydroxychloroquine blocking TLR9 in rheumatoid arthritis, but explicitly says it 'could only' block TLR9 and proposes combining it with a separate cGAS inhibitor. That contradicts the claim that this paper attributes cGAS antagonism to hydroxychloroquine. The cited passages do not establish this mechanism as contributing to its clinical efficacy in systemic lupus erythematosus; page numbers are unavailable in our copy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972 · see citing works
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L. Y., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,665 · see citing works
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hú, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070 · see citing works
Self-citationPlasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · see citing works
COVID-19 infection: the perspectives on immune responses
Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., Bucci, E. M., Piacentini, M., Ippolito, G., & Melino, G. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0530-3 · Cited by 1,602 · see citing works
Self-citationBrand, D. D., Latham, K. A., & Rosloniec, E. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.173 · Cited by 1,419 · see citing works
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190 · see citing works
Development and Function of Dendritic Cell Subsets
Mildner, A., & Jung, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.016 · Cited by 762 · see citing works
Krug, A., French, A. R., Barchet, W., Fischer, J. A. A., Dzionek, A., Pingel, J. T., Orihuela, M. M., Akira, S., Yokoyama, W. M., & Colonna, M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.007 · Cited by 727 · see citing works
Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines
Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000702 · Cited by 606 · see citing works
Rainsford, K. D., Parke, A. L., Clifford‐Rashotte, M., & Kean, W. F. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0239-y · Cited by 542 · see citing works
Hornung, V., & Latz, E. (2010) · Nature reviews. Immunology · doi:10.1038/nri2690 · Cited by 366 · see citing works
Genetic models of human and mouse dendritic cell development and function
Anderson, D. A., Dutertre, C., Ginhoux, F., & MURPHY, K. M. M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00413-x · Cited by 314 · see citing works
Ruchatz, H., Leung, B. P. L., Wei, X., McInnes, I. B., & Liew, F. Y. (1998) · PubMed · Cited by 290 · see citing works
Dendritic cells as gatekeepers of tolerance
Waisman, A., Lukas, D., Clausen, B. E., & Yogev, N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0583-z · Cited by 253 · see citing works
Ruchatz, H., Leung, B. P. L., Wei, X., McInnes, I. B., & Liew, F. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5654 · Cited by 218 · see citing works
Tang, T., Lv, L., Pan, M.-M., Wen, Y., Wang, B., Li, Z., Wu, M., Wang, F., Crowley, S. D., & Liu, B. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0378-3 · Cited by 209 · see citing works
Protocol for the induction of arthritis in C57BL/6 mice
Inglis, J. J., Šimelyte, E., McCann, F. E., Criado, G., & Williams, R. O. (2008) · Nature Protocols · doi:10.1038/nprot.2008.19 · Cited by 188 · see citing works
Transcriptional Networks Driving Dendritic Cell Differentiation and Function
Nutt, S. L., & Chopin, M. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.005 · Cited by 164 · see citing works
Dieker, J. W. C., Tel, J., Pieterse, E., Thielen, A. J. F., Rother, N., Bakker, M. A. H., Fransen, J., Dijkman, H. B. P. M., Berden, J. H. M., de Vries, I. J. M., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39417 · Cited by 161 · see citing works
Zaru, R., Ronkina, N., Gaestel, M., Arthur, J. S. C., & Watts, C. K. W. (2007) · Nature Immunology · doi:10.1038/ni1517 · Cited by 143 · see citing works
In vitro inhibition of human influenza A virus replication by chloroquine.
Ooi, E. E., Chew, J. S. W., Loh, J. P., & Chua, R. (2006) · Virology Journal · doi:10.1186/1743-422x-3-39 · Cited by 142 · see citing works
Zhitomirsky, B., Yunaev, A., Kreiserman, R., Kaplan, A., Stark, M., & Assaraf, Y. G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1227-0 · Cited by 119 · see citing works
Terhorst‐Molawi, D., Chelbi, R., Wohn, C., Malosse, C., Tamoutounour, S., Jorquera, A., Bajénoff, M., Dalod, M., MALISSEN, B., & Henri, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500551 · Cited by 100 · see citing works
Mok, C. C., Penn, H. J., Chan, K. L., Tse, S. M., Langman, L. J., & Jannetto, P. J. (2016) · Arthritis Care & Research · doi:10.1002/acr.22837 · Cited by 93 · see citing works
Turning NF-κB and IRFs on and off in DC
Kaisho, T., & Tanaka, T. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.03.005 · Cited by 87 · see citing works
Li, X., Han, Y., Zhou, Q., Jie, H., He, Y., Han, J., He, J., Jiang, Y., & Sun, E. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12717 · Cited by 76 · see citing works
Self-citationThe function of myeloid dendritic cells in rheumatoid arthritis
Yu, M. B., & Langridge, W. H. R. (2017) · Rheumatology International · doi:10.1007/s00296-017-3671-z · Cited by 75 · see citing works
Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors
Zanoni, I., & Granucci, F. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0638-x · Cited by 68 · see citing works
Han, Y., Li, X., Zhou, Q., Jie, H., Lao, X., Han, J., He, J., Liu, X., Gu, D., He, Y., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401842 · Cited by 68 · see citing works
Self-citationDendritic cell development—History, advances, and open questions
Puhr, S., Lee, J., Zvezdova, E., Zhou, Y. J., & Liu, K. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.012 · Cited by 60 · see citing works
Hydroxychloroquine’s Efficacy as an Antiplatelet Agent Study in Healthy Volunteers
Achuthan, S., Ahluwalia, J., Shafiq, N., Bhalla, A., Pareek, A., Chandurkar, N., & Malhotra, S. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414546324 · Cited by 55 · see citing works
Dong, C., Liu, Y., Sun, C., Liang, H., Dai, L., Shen, J., Wei, S., Guo, S., Leong, K. W., Chen, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00662 · Cited by 49 · see citing works
Estrada‐Capetillo, L., Hernández-Castro, B., Monsiváis-Urenda, A. E., Álvarez-Quiroga, C., Layseca‐Espinosa, E., Abud‐Mendoza, C., Baranda, L., Urzainqui, A., Sánchez‐Madrid, F., & González‐Amaro, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/584303 · Cited by 48 · see citing works
Gustafsson, K. T., Karlsson, M. C. I., Andersson, L., & Holmdahl, R. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200935 · Cited by 45 · see citing works
Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
Ahmed, M. S., & Bae, Y. (2016) · Immune Network · doi:10.4110/in.2016.16.1.44 · Cited by 39 · see citing works
He, J., Li, X., Zhuang, J., Han, J., Luo, G., Yang, F., Sun, Y., Liao, P., Han, Y., He, Y., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800412 · Cited by 31 · see citing works
Self-citationAbdelal, I. T., Zakaria, M. A., Sharaf, D. M., & el-akad, G. (2016) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2016.06.005 · Cited by 30 · see citing works
Liu, C., Wang, M., Sun, W., Cai, F., Geng, S., Su, X., & Shi, Y. P. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6504 · Cited by 23 · see citing works
Ramwadhdoebé, T. H., Ramos, M. I. P., Maijer, K. I., van Lienden, K. P., Maas, M. M., Gerlag, D. M., Tak, P. P., Lebre, M. C., & van Baarsen, L. G. M. (2019) · Cells · doi:10.3390/cells8070756 · Cited by 14 · see citing works
Han, J., Zhou, Q., Li, X., He, J., Han, Y., Jie, H., He, Y., & Sun, E. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.132 · Cited by 13 · see citing works
Self-citationDendritic cell development: A personal historical perspective
Shortman, K. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2019.12.016 · Cited by 13 · see citing works
Improvement of vitiligo in a patient with rheumatoid arthritis after hydroxychloroquine treatment
Joo, K., Park, W., Kwon, S., Lim, M. J., & Jung, K. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12442 · Cited by 11 · see citing works
Martínez-García, E. A., Zavala-Cerna, M. G., Lujano-Benítez, A. V., Sánchez‐Hernández, P. E., Martín-Márquez, B. T., Sandoval-García, F., & Mercado, M. V.-D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01497 · Cited by 9 · see citing works
Increased generation of pre-plasmacytoid dendritic cells in bone marrow of rheumatoid arthritis
Hirohata, S., Yanagida, T., Tomita, T., & Yoshikawa, H. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.843759 · Cited by 8 · see citing works
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs
Jing, W., Liu, C., Su, C.-H., Liu, L., Chen, P., Li, X., Xinghua, Z., Yuan, B., Wang, H., & Xiaozheng, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107670 · Cited by 143 · see citing works
Self-citationHu, Y., Chen, B., Yang, F., Su, Y., Yang, D., Yao, Y., Wang, S., Wu, Y., Tao, L., & Xu, T. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103155 · Cited by 92 · see citing works
Self-citationMultifunctional nanoparticle for cancer therapy
Gao, Y., Wang, K., Zhang, J. C., Duan, X., Sun, Q., & Men, K. (2023) · MedComm · doi:10.1002/mco2.187 · Cited by 79 · see citing works
Macrophage-Targeted Hydroxychloroquine Nanotherapeutics for Rheumatoid Arthritis Therapy
Fang, H., Sha, Y., Yang, L., Jiang, J., Yin, L., Li, J., Li, B., Klumperman, B., Zhong, Z., & Meng, F. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c23429 · Cited by 66 · see citing works
The great obstetrical syndromes and the placenta
Hoffman, M. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17613 · Cited by 67 · see citing works
Saber, M. M., Monir, N., Awad, A. S., Elsherbiny, M. E., & Zaki, H. F. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120874 · Cited by 59 · see citing works
The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives
An, C., Li, Z., Chen, Y., Huang, S., Yang, F., Hu, Y., Xu, T., Zhang, C., & Ge, S. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01242-4 · Cited by 45 · see citing works
Self-citationChen, M., Yadav, V. K., Chu, Y. C., Ong, J. R., Huang, T.-Y., Lee, K.-F., Lee, K., Yeh, C., & Lee, K. (2021) · Cancers · doi:10.3390/cancers13133227 · Cited by 44 · see citing works
Effect of DMARDs on the immunogenicity of vaccines
van Sleen, Y., van der Geest, K. S. M., Huckriede, A. L. W., van Baarle, D., & Brouwer, E. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00992-8 · Cited by 36 · see citing works
Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis
Lehmann, J., Giaglis, S., Kyburz, D., Daoudlarian, D., & Walker, U. A. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03329-2 · Cited by 36 · see citing works
Mârțu, M.-A., Maftei, G.-A., Luchian, I. A., Ștefănescu, O. M., Scutariu, M. M., & Solomon, S. M. (2021) · Pharmaceuticals · doi:10.3390/ph14121209 · Cited by 33 · see citing works
Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One?
Santos‐Sierra, S. (2021) · Biomolecules · doi:10.3390/biom11091291 · Cited by 32 · see citing works
Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cells
Kim, M. L., Hardy, M. Y., Edgington‐Mitchell, L. E., Ramarathinam, S. H., Chung, S. Z., Russell, A. K., Currie, I., Sleebs, B. E., Purcell, A. W., Tye–Din, J. A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103509 · Cited by 25 · see citing works
Purdy, R., John, M., Bray, A., Clare, A. J., Copland, D. A., Chan, Y. K., Henderson, R. H., Nerinckx, F., Leroy, B. P., Yang, P., et al. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101354 · Cited by 24 · see citing works
“Hydroxychloroquine has been purported to interact with and antagonise the key intracellular nucleic acid sensors, TLR9 and cGAS, which likely contribute to its clinical efficacy in rheumatoid arthritis and systemic lupus erythematous (Han et al., 2020).”
Mao, C.-L., Yu, C.-H., Jiang, S.-L., Ying, Z., & Zhu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1717671 · Cited by 23 · see citing works
Zhao, Y., Wu, C., Liang, X., & Yang, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1640748 · Cited by 22 · see citing works
Luo, X., Zhai, Z., Lin, Z., Wu, S., Xu, W., Li, Y., Zhuang, J., Li, J., Yang, F., & He, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110244 · Cited by 21 · see citing works
Self-citationChatterjee, A., Jayaprakasan, M., Chakrabarty, A. K., Lakkaniga, N. R., Bhatt, B. N., Banerjee, D., Narwaria, A., Katiyar, C. K., & Dubey, S. K. (2024) · Phytotherapy Research · doi:10.1002/ptr.8187 · Cited by 20 · see citing works
Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer
Niemann, B. R., Puleo, A., Stout, C., Markel, J., & Boone, B. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122551 · Cited by 19 · see citing works
Shuai, L., She, J., Diao, R., Zhao, H., Liu, X., Hu, Q., Li, D., Su, D., Ye, X., Guo, Y. P., et al. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13686 · Cited by 16 · see citing works
Gajić, M., Schröder‐Heurich, B., & Mayer-Pickel, K. I. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1298928 · Cited by 14 · see citing works
Chloroquine and hydroxychloroquine: Immunomodulatory effects in autoimmune diseases
Al-Hamadani, M., Darweesh, M. F., Mohammadi, S., & Al‐Harrasi, A. (2025) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v16.i2.107042 · Cited by 12 · see citing works
Ghincea, A., Woo, S., Yu, S., Pivarnik, T., Fiorini, V., Herzog, E. L., & Ryu, C. (2023) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-023-00211-1 · Cited by 11 · see citing works
Siddique, S., Hussain, K., Shehzadi, N., Arshad, M. N., Arshad, M. N., Iftikhar, S., Saghir, F., Shaukat, A., Sarfraz, M., & Ahmed, N. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob00040d · Cited by 9 · see citing works
Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?
Xu, C., Jing, W., Liu, C., Yuan, B., Zhang, X., Liu, L., Zhang, F., Chen, P., Liu, Q., Wang, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343325 · Cited by 9 · see citing works
Yang, Q., Zhang, F., Chen, H., Hu, Y., Yang, N., Yang, W., Wang, J., Yang, Y., Xu, R., & Xu, C. (2023) · Bioscience Reports · doi:10.1042/bsr20231723 · Cited by 9 · see citing works
Umbreen, H., Zhang, X., Tang, K., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010238 · Cited by 8 · see citing works
Trujillo, G., Regueiro‐Ren, A., Liu, C., Hu, B., Sun, Y. S., Ahangari, F., Fiorini, V., Ishikawa, G., Jumaily, K. A., Khoury, J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0065oc · Cited by 8 · see citing works
dos Santos, A. P. R., Vaz, C. D. O., Hounkpe, B. W., Jacintho, B. C., Oliveira, J. D., Mesquita, G. L. T. V., dos Santos, I. P., Annichino‐Bizzacchi, J. M., Appenzeller, S., Mazetto, B. D. M., et al. (2022) · Lupus · doi:10.1177/09612033221101731 · Cited by 7 · see citing works
Kast, R. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015474 · Cited by 7 · see citing works
TLR9: A Double-Dealing Toll-Like Receptor
Nielsen, M., Nishizaki, D., Kato, S., & Kurzrock, R. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s563765 · Cited by 6 · see citing works
Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?
Jatta, N., Stanslas, J., Yong, A. C. H., Ho, W. C., Kammal, W. S. L. W. A., Chua, E. W., & How, K. N. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01142-w · Cited by 6 · see citing works
Chen, S., Hu, H., Wu, J., Dong, M., Zhang, Y., Zhu, Q., Wang, Z., Sun, Y. K., & Gao, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113910 · Cited by 6 · see citing works
Babataheri, S., Malekinejad, H., Mosarrezaii, A., & Soraya, H. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12856 · Cited by 6 · see citing works
Li, Z., Liu, Y., Zhang, Y., Zhang, Z., Lei, S., & Shen, H. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07543-4 · Cited by 4 · see citing works
Zhu, K., Zhang, X., Chen, G., Zhu, Y., Wang, K., Zhang, Q., Jin, Z., Shu, Q., Tang, X., Chen, H., et al. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07583-w · Cited by 4 · see citing works
Bai, Y., Perng, W., Huang, J., Liao, P., & Wei, J. C. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.15099 · Cited by 3 · see citing works
Dong, C., Chen, B. S., Wu, C. H., Chiu, Y., Liao, P., & Perng, W. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.15286 · Cited by 3 · see citing works
Hydroxychloroquine Improves Low Complement Levels
Jacobson, R., GOLDMAN, D. W., Fava, A., Magder, L. S., & Petri, M. (2024) · Arthritis Care & Research · doi:10.1002/acr.25381 · Cited by 2 · see citing works
Zou, M., Guo, K., Qian, D., Cheng, Y.-C., Xu, G., & Ge, S.-W. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128347345241028063515 · Cited by 2 · see citing works
Fang, S., Xu, X., Zhong, L., Wang, A.-Q., Gao, W., Lu, M., & Yin, Z. (2021) · Immunogenetics · doi:10.1007/s00251-021-01224-7 · Cited by 2 · see citing works
Lipid metabolism at the intersection of rheumatoid arthritis and atherosclerosis
Fang, X., Chen, H., Yang, X., Du, W., Wang, S. L., Yang, X., Lao, T., Chen, W., Shi, Y., Tian, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1790634 · Cited by 1 · see citing works
Dráfi, F., Poništ, S., Sepodes, B. M. N., & Bauerová, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00110-9 · Cited by 1 · see citing works
Emerging Trends and Research on Hydroxychloroquine Treatment in Diseases From 1991 to 2020Preprint
Kong, L., Wang, Y.-N., & Zhang, W. (2021) · Research Square · doi:10.21203/rs.3.rs-227203/v1
Fang, S., Fang, X., Xu, X. P., Zhong, L., Wang, A., Gao, W., & Yin, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-296982/v1
Autoimmune diseases and the role of Toll-like receptor-7 and -9 signaling cascades
Keller, E. J., Patel, N. B., & Jørgensen, T. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822564-6.00004-5
Hydroxychloroquine: Chemistry and Medicinal Applications
Singh, R., Tyagi, Y. K., & Yadav, N. (2023) · Heterocycles · doi:10.3987/rev-22-993
Mesenchymal stem cells for rheumatoid arthritis
Ichim, T. E., Ramos, R. A., Agamirov, A., Berry, S. K., Rath, A. V., Bykoriz, V., Nicole, E. U., Vyrlanovitch, M., Azimi, N. A., Reynolds, S., et al. (2025) · Journal of Stem Cell Research & Therapeutics · doi:10.15406/jsrt.2025.10.00187
Mainieri, L., Kaufmann, A., Bucci, L., Grieshaber‐Bouyer, R., Bauer, S., & Solis, F. V. (2025) · Lara D. Veeken · doi:10.1093/rheumatology/keaf537
- Authors
- Han, J., Li, X., Luo, X., He, J., Huang, X., Zhou, Q., Han, Y., Jie, H., Zhuang, J., Li, Y., Yang, F., Zhai, Z., Wu, S., He, Y., Yang, B., & Sun, E.
- Affiliations
- Third Affiliated Hospital of Southern Medical University (CN)
- Peking University Shenzhen Hospital (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
- South China Normal University (CN)
- Corresponding author
- He, Yi
- Yang, Bin
- Sun, Erwei
- ORCID
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 132
- Pages
- 110848
- ISSN
- 0753-3322 (ISSN-L)
- PMC
- PMC7547638
- OpenAlex
- W3092456362
- Cited by
- 49
- References
- 46
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 12 · 2023: 11 · 2022: 7 · 2021: 9
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- hydroxychloroquine, rheumatoid arthritis, dendritic cells, TLR9, T follicular helper cells, dendritic cell maturation, dendritic cell migration, interferon-alpha, CXCR4, CCR7, L-selectin, IL-12, collagen-induced arthritis, TLR9-deficient mice, immunosuppression
- MeSH terms
- Adult, Aged, Animals, Arthritis, Experimental, Arthritis, Rheumatoid, Dendritic Cells, Female, Humans, Hydroxychloroquine, Male, Mice, Inbred C57BL, Mice, Inbred DBA, Middle Aged, Signal Transduction, Down-Regulation, Case-Control Studies, Mice, Knockout, Antirheumatic Agents, Toll-Like Receptor 9, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review